Please login to the form below

Not currently logged in
Email:
Password:

bitopertin

This page shows the latest bitopertin news and features for those working in and with pharma, biotech and healthcare.

Abilify Maintena launches in Europe

Abilify Maintena launches in Europe

Prospects for drugs that tackle the latter remain up in the air, however; Roche's bitopertin was leading the field but generated poor results in two phase III trials reported earlier

Latest news

  • Setback for Roche as schizophrenia candidate fails studies Setback for Roche as schizophrenia candidate fails studies

    Like bitopertin both of these were being tested as add-on drugs to tackle negative symptoms, but had different mechanisms of action. ... Analysts have suggested in the past that bitopertin could achieve sales of $3bn or more if it proves effective in

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics